{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T13:49:10Z","timestamp":1735048150063,"version":"3.32.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jmii.2024.08.005","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:06:23Z","timestamp":1723680383000},"page":"840-853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of liver fibrosis changes assessed by paired liver biopsies in chronic hepatitis C patients treated with direct-acting antivirals"],"prefix":"10.1016","volume":"57","author":[{"given":"Ming-Han","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Yu","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Hui","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Chi","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Yuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsueh-Chou","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsing-Hung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Wang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Yu","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Ta","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jmii.2024.08.005_bib1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"author":"Hepatitis","key":"10.1016\/j.jmii.2024.08.005_bib2"},{"issue":"1","key":"10.1016\/j.jmii.2024.08.005_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"EASL recommendations on treatment of hepatitis C 2016","volume":"66","year":"2017","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jmii.2024.08.005_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jmii.2024.08.005_bib5","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series","volume":"73","year":"2020","journal-title":"J Hepatol"},{"issue":"1 Suppl","key":"10.1016\/j.jmii.2024.08.005_bib6","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.jhep.2016.08.001","article-title":"Management of the patient with SVR","volume":"65","author":"Terrault","year":"2016","journal-title":"J Hepatol"},{"issue":"Suppl 4","key":"10.1016\/j.jmii.2024.08.005_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","article-title":"The etiology of hepatocellular carcinoma and consequences for treatment","volume":"15","author":"Sanyal","year":"2010","journal-title":"Oncol"},{"issue":"1","key":"10.1016\/j.jmii.2024.08.005_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.jmii.2024.08.005_bib9","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cmi.2016.09.017","article-title":"Role of assessing liver fibrosis in management of chronic hepatitis C virus infection","volume":"22","author":"Carmona","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.jmii.2024.08.005_bib10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2013.05.015","article-title":"Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C","volume":"59","author":"Poynard","year":"2013","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jmii.2024.08.005_bib11","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3390\/medicina59040814","article-title":"Impact of direct-acting antiviral therapy on liver fibrosis regression among people with chronic HCV infection: results from a real-life cohort in patients who achieved sustained virological response","volume":"59","author":"Garc\u00eda-Ros","year":"2023","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.jmii.2024.08.005_bib12","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1038\/s41598-022-08955-x","article-title":"Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: a prospective study","volume":"12","author":"Thanapirom","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jmii.2024.08.005_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41598-021-03272-1","article-title":"Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents","volume":"12","author":"Yoo","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jmii.2024.08.005_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jvh.13617","article-title":"Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicentre prospective study","volume":"29","author":"Rosato","year":"2022","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jmii.2024.08.005_bib15","article-title":"Long-term impact of hepatitis C virus eradication on liver stiffness in Egyptian patients","volume":"2021","author":"Zakareya","year":"2021","journal-title":"Chin J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jmii.2024.08.005_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MEG.0000000000001259","article-title":"Different kinetics of liver stiffness using shear wave elastography in patients with chronic hepatitis C infection treated with interferon-free regimens","volume":"31","author":"Attia","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.jmii.2024.08.005_bib17","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1177\/2050640618786067","article-title":"Long-term changes in liver elasticity in hepatitis C virus-infected patients with sustained virologic response after treatment with direct-acting antivirals","volume":"6","author":"Pietsch","year":"2018","journal-title":"United European Gastroenterol J"},{"issue":"5","key":"10.1016\/j.jmii.2024.08.005_bib18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/MEG.0000000000001106","article-title":"Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response","volume":"30","author":"Kobayashi","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.jmii.2024.08.005_bib19","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/apt.14554","article-title":"Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy","volume":"47","author":"Tada","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jmii.2024.08.005_bib20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jmv.24950","article-title":"Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b","volume":"90","author":"Ogasawara","year":"2018","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.jmii.2024.08.005_bib21","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s10620-017-4749-x","article-title":"Direct-acting antiviral therapy for chronic HCV infection results in liver stiffness regression over 12 Months post-treatment","volume":"63","author":"Chan","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.jmii.2024.08.005_bib22","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/jgh.13788","article-title":"Improvement of liver stiffness in patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response","volume":"32","author":"Tada","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jmii.2024.08.005_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/liv.13256","article-title":"Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index","volume":"37","author":"Bachofner","year":"2017","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.jmii.2024.08.005_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.15403\/jgld.2014.1121.262.dyn","article-title":"Dynamics of liver stiffness values by means of transient elastography in patients with HCV liver cirrhosis undergoing interferon free treatment","volume":"26","author":"Sporea","year":"2017","journal-title":"J Gastrointestin Liver Dis"},{"issue":"12","key":"10.1016\/j.jmii.2024.08.005_bib25","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/jvh.12578","article-title":"Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy","volume":"23","author":"Knop","year":"2016","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.jmii.2024.08.005_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3350\/cmh.2018.0029","article-title":"Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients","volume":"25","author":"M\u00f6lleken","year":"2019","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"10.1016\/j.jmii.2024.08.005_bib27","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jfma.2020.11.018","article-title":"Direct-acting antiviral therapy of chronic hepatitis C improves liver fibrosis, assessed by histological examination and laboratory markers","volume":"120","author":"Cheng","year":"2021","journal-title":"J Formos Med Assoc"},{"issue":"9","key":"10.1016\/j.jmii.2024.08.005_bib28","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1177\/2050640618791053","article-title":"Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C","volume":"6","author":"Enomoto","year":"2018","journal-title":"United European Gastroenterol J"},{"issue":"11","key":"10.1016\/j.jmii.2024.08.005_bib29","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/hep4.1228","article-title":"Morphometry confirms fibrosis regression from sustained virologic response to direct-acting antivirals for hepatitis C","volume":"2","author":"Pan","year":"2018","journal-title":"Hepatol Commun"},{"issue":"2","key":"10.1016\/j.jmii.2024.08.005_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10238-022-00799-z","article-title":"Liver biopsy for assessment of chronic liver diseases: a synopsis","volume":"23","author":"Chowdhury","year":"2023","journal-title":"Clin Exp Med"},{"issue":"7","key":"10.1016\/j.jmii.2024.08.005_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jmii.2024.08.005_bib32","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/j.gastro.2020.09.065","article-title":"Fibrosis regression after eradication of hepatitis C virus: from bench to bedside","volume":"160","author":"Rockey","year":"2021","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jmii.2024.08.005_bib33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/cmi.2015.104","article-title":"Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies","volume":"13","author":"Ju","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jmii.2024.08.005_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/20406223211067631","article-title":"Long-term surveillance of liver histological changes in chronic hepatitis C patients completing pegylated interferon-\u03b1 plus ribavirin therapy: an observational cohort study","volume":"13","author":"Hsieh","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"issue":"1","key":"10.1016\/j.jmii.2024.08.005_bib35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/liv.14229","article-title":"Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease","volume":"40","author":"Scheiner","year":"2020","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.jmii.2024.08.005_bib36","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/liv.13317","article-title":"Thrombocytopenia in chronic liver disease","volume":"37","author":"Peck-Radosavljevic","year":"2017","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.jmii.2024.08.005_bib37","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0016-5085(00)70364-7","article-title":"Liver fibrosis in overweight patients","volume":"118","author":"Ratziu","year":"2000","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jmii.2024.08.005_bib38","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.510290401","article-title":"Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis","volume":"29","author":"Hourigan","year":"1999","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jmii.2024.08.005_bib39","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1111\/j.1572-0241.2002.05995.x","article-title":"Contribution of obesity to hepatitis C-related fibrosis progression","volume":"97","author":"Ortiz","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jmii.2024.08.005_bib40","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C","volume":"122","author":"Poynard","year":"2002","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jmii.2024.08.005_bib41","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/hep.21239","article-title":"Impact of obesity on treatment of chronic hepatitis C","volume":"43","author":"Charlton","year":"2006","journal-title":"Hepatology"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168411822400149X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168411822400149X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T13:04:39Z","timestamp":1735045479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S168411822400149X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S168411822400149X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2024.08.005","relation":{},"ISSN":["1684-1182"],"issn-type":[{"type":"print","value":"1684-1182"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of liver fibrosis changes assessed by paired liver biopsies in chronic hepatitis C patients treated with direct-acting antivirals","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2024.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC\u00e9","name":"copyright","label":"Copyright"}]}}